Clinical use of Four-dimensional Computed Tomography Scans

Clinical use of Four-dimensional Computed Tomography Scans

European Oncology Review 2005
Published: October 2008
dots

The Impact of Mobility on High-precision Radiotherapy
The goal of conformal radiation therapy is to precisely deliver high doses to the tumour while minimising doses to surrounding critical structures. Recent technical developments such as intensity-modulated radiotherapy (IMRT) have made it possible to deliver highly conformal radiation dose distributions to complex three-dimensional (3-D) target volumes. High-precision techniques, such as IMRT, stereotactic radiotherapy (SRT) and respiration-gated radiotherapy, are promising tools for dose escalation in the management of thoracic and abdominal lesions. One example is the local control rates in excess of 85% that were achieved for small peripheral lung tumours with SRT using biologically effective doses of 106 to 180Gy.1,2 However, tumours and organs in the thorax and upper abdomen can exhibit considerable mobility, leading to important errors between planned and delivered dose distributions. The inability to accurately characterise tumour and organ mobility for an individual patient remains a major impediment to the clinical application of highprecision radiotherapy.

Radiotherapy planning of tumours in the thorax and upper abdomen is commonly based on the use of a single computed tomography (CT) scan performed during quiet respiration, in contrast to diagnostic CT scans, which are performed during breath-hold. The reason for performing CT scans during quiet respiration is to reproduce the situations during daily treatment that take place under similar conditions. However, this introduces artefacts that incorrectly characterise the geometric shape and extent of a structure.3 As has been demonstrated using phantom studies,4 the extent of artefacts depends on the interplay between CT slice acquisition and the asynchronous motion of different organs. This may result in tumours being imaged in two or more distinct parts, with the axial slices being shuffled out of order (see Figure 1). Furthermore, nonrepresentative imaging using a conventional planning CT scan also leads to incorrect information on normal organ size and position, with inaccurate information on the actual dose-distribution in these structures. Respiration-induced organ motion greatly degrades the potential effectiveness of advanced treatment planning and delivery. Until recently, the problem of doses to mobile normal organs was largely ignored in routine practice, but standard ‘safety’ margins were added around tumours in order to ensure target coverage. Studies have shown that even these margins may be insufficient to account for extremes of mobility 5–7 and may increase the risks of toxicity to surrounding organs, which in turn limits the total dose of radiotherapy.

Individualised Approach to Tumour and Organ Mobility
Individualised, i.e. patient-specific, margins are required to account for mobility as no clear correlation exists between mobility and anatomical location in the thorax.6–8 A major advance in this field is respiration-correlated (4-D) CT scanning in which spatial and temporal information on organ mobility are generated using cine scans, while the respiratory waveform is synchronously recorded during imaging. As multiple axial CT slices are acquired at each table position for at least the duration of one full respiratory cycle, this approach yields complete data on organ mobility in the prescribed trajectory. The clinical data described below was mainly generated on a 16-slice CT scanner during quiet uncoached respiration. During the scanning procedure, respiratory signals are recorded using Varian Real-Time Position Management (RPM) respiratory monitoring hardware. The RPM system uses infrared-reflecting markers mounted on a block that is placed on the upper abdomen. Advantage 4-D software was used to sort each CT image into one of 10 ‘bins’ corresponding to the respiratory phase at which the image was captured. A 4-D CT scan is essentially a collection of 3-D CT volumes at all different respiratory phases in the patient, all of which is acquired in a single session. Such a full 4-D scan of the whole thorax is typically acquired within one to two minutes.

Other methods that have been described for acquiring co-registered respiratory signals include spirometry, nasal thermocouples and abdominal strain gauges. If 4-D information is to be used for gated treatment delivery, the method used to acquire respiratory information should also be present at the treatment unit.

References:
  1. Onishi H, Araki T, Shirato H, et al., "Stereotactic Hypofractionated High-Dose Irradiation for Stage I Nonsmall Cell Lung Carcinoma. Clinical Outcomes in 245 Subjects in a Japanese Multiinstitutional Study", Cancer (2004);101: pp. 1,623-1,631.
  2. Timmerman R, Papiez L, McGarry R, et al., "Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer", Chest (2003);124: pp. 1,946-1,955.
  3. Balter J M, Ten Haken R K, Lawrence T S, et al., "Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing", Int. J. Radiat. Oncol. Biol. Phys. (1996);36: pp. 167-174.
  4. Pan T, Lee T Y, Rietzel E, Chen G T, "4D-CT imaging of a volume influenced by respiratory motion on multi-slice CT", Med. Phys. (2004);31: pp. 333-340.
  5. van Sörnsen de Koste J R, Lagerwaard F J, Schuchhard-Schipper R H, et al., "Dosimetric consequences of tumor mobility in radiotherapy of stage I non-small cell lung cancer- an analysis of data generated using slow CT scans", Radiother. Oncol. (2001);61: pp. 93-99.
  6. Plathow C, Ley S, Fink C, et al., "Analysis of Intrathoracic Tumor Mobility During Whole breathing Cycle By Dynamic MRI", Int. J. Radiation Oncology Biol. Phys., (2004);Vol. 59, No. 4, pp. 952-959.
  7. Underberg R W M, Lagerwaard F J, Slotman B J, Cuijpers J P, Senan S, "Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer - An analysis of 4DCT datasets", Int. J. Radiat. Oncol. Biol. Phys. (2005);62: pp. 554-560.
  8. van Sörnsen de Koste J R, Lagerwaard F J, Nijssen-Visser M R, et al., "Tumor location cannot predict the mobility of lung tumors: a 3D analysis of data generated from multiple CT scans", Int. J. Radiat. Oncol. Biol. Phys. (2003);56: pp. 348-354.
  9. Keall P, "4-Dimensional computed tomography imaging and treatment planning", Semin. Radiat. Oncol. (2004);14: pp. 81-90.
  10. Lagerwaard F J, van Sornsen de Koste J R, Nijssen-Visser M R J, et al., "Multiple slow CT scans for incorporating lung tumor mobility in radiotherapy planning", Int. J. Radiat. Oncol. Biol. Phys. (2001);51: pp. 932-937.
  11. van Sörnsen de Koste J R, Lagerwaard F J, Schuchhard-Schipper R H, et al., "Dosimetric consequences of tumor mobility in radiotherapy of stage I non-small cell lung cancer- an analysis of data generated using slow CT scans", Radioth. Oncol. (2001);61: pp. 93-99.
  12. Underberg R W M, Lagerwaard F J, Cuijpers J P, et al., "4-Dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer", Int. J. Radiat. Oncol. Biol. Phys. (2004);60: pp. 1,283-1,290.
  13. van der Geld Y, Senan S, van Sornsen de Koste J R, et al., "Determining lung tumor mobility for radiotherapy planning: A comparison of fluoroscopy and 4D CT data", Proceedings of the 11th World Conference on Lung Cancer, Barcelona, 3-6 July 2005.
  14. Underberg R W M, van Sörnsen de Koste J R, Slotman B J, Senan S, "Respiration-gated radiotherapy in stage III NSCLC: an analysis of data generated using 4D CT scanning", Proceedings of the 11th World Conference on Lung Cancer, Barcelona, 3-6 July 2005.
  15. Underberg R W M, Lagerwaard F J, Slotman B J, Cuijpers J P, Senan S, "Use of maximum intensity projections for target volume generation in 4DCT scans for lung cancer", Int. J. Radiat. Oncol. Biol. Phys. In press.
  16. Kini V R, Vedam S S, Keall P J, et al., "Patient training in respiratory-gated radiotherapy", Med. Dosim. (2003);28: pp. 7-11.

Copyright® 2004 - 2010 Business Briefings, Ltd. All rights reserved.
Touch Oncology is for informational purposes and should not be considered medical advice, diagnosis or treatement recommendations.